Orbit Discovery and SanegeneBio collaborate to identify targeting peptides for RNAi drugs
Orbit Discovery Limited (Orbit), a leader in the discovery of therapeutic peptide hits, today announced it has entered into a Master Service Agreement with SanegeneBio Inc., (Sanegene), a start-up company dedicated to developing novel RNAi-based medicines.
PhoreMost reaches milestone in a Target Discovery Alliance with Boehringer Ingelheim
PhoreMost Ltd., has triggered a milestone payment in its multi-project target discovery collaboration with Boehringer Ingelheim. This was achieved by identifying and validating novel targets supporting Boehringer Ingelheim’s ambition to develop first-in-class therapies, to transform patients’ lives.
Spatial lung cell atlas offers insights into disease and immune function
The most comprehensive lung cell atlas to date, from the Wellcome Sanger Institute and collaborators, has revealed 11 new lung cell types and offers detailed insight into an immune process involved in fighting lung infections.
Cambridge health technology consultancy gears for growth with new hires
Health Tech Enterprise (HTE), a Cambridge-based health technology consultancy, has expanded its team with two strategic new hires, marking a period of ongoing growth for the company.
Cambridge Healthcare Research reveals new brand identities to support its ambitious growth trajectory
Cambridge Healthcare Research has unveiled an extensive rebrand across its divisions. The rebrand includes a move to a house of brands model and sees the competitive intelligence arm of the business renamed and reimagined as Solici.
IHT receipts rise again
HMRC has published details of tax receipts for April to November 2022- A tax paid by people hate relatives more than the tax man !
Supplement advice for New Year vegans
An expert group co-founded by an Addenbrooke’s clinician has issued a “cautionary message” to those thinking of moving to a plant-based diet this January.
Taking the Sting out of Vaccines
Cast your mind into the future and imagine the world in the grips of the next global respiratory pandemic. We have the monumental task of vaccinating the world against a novel pathogen. How should we achieve this?
Robot-assisted surgical trends in 2023 and beyond
Robotic-assisted surgery has been making its way into the operating room (OR) for decades, boosting minimally invasive general surgery, enhancing orthopaedics, and enabling precision-guided catheter systems—with continued improvements leading to complex systems such as Intuitive’s market-leading da Vinci. The benefits of these systems are widely accepted: articulated tools and HD cameras provide…
Mission Street lodges plans for £100m Oxford R&D hub
Scheme is to provide 182,900 sq ft of science and innovation workspace
MPs addressed on importance of sensory loss survey
Westminster hears plans for inaugural assessment of UK’s vision and hearing health
Rare Disease: A year in review
As more investments have been made in developing and commercializing treatments for rare diseases, the experience and expertise of our CRA teams have grown.
CN Bio appoints Dr Paul Brooks as Chief Executive Officer
Key strategic appointment as the Company enters next phase of commercial growth and global expansion of its products and services Former CEO, Dr David Hughes, appointed to Scientific Advisory BoardCambridge, UK, 19 December 2022:
New associate director joins CPFT research leadership team
Cambridgeshire and Peterborough NHS Foundation Trust (CPFT) welcomes Rasha DeMarco as the newly appointed Associate Director of Research and Development to lead on operational delivery and grow the Trust’s research portfolio.
Expansion continues for Biocair as firm reports substantial growth
The pharmaceutical, biotech and life sciences logistics expert, Biocair is marking another year of significant growth as it reports a 30% increase in sales volume year on year. Whilst also more than doubling its headcount to over 560 staff globally during the last two years.
Anthias Consulting partner with HEaTED to promote technical training courses
Anthias Consulting Ltd are pleased to announce a collaboration with HEaTED to provide their members with a 15% discount on Anthias scheduled courses in analytical science techniques.
Global Access Diagnostics joins consortium to co-develop on-farm rapid test for calf pneumonia, RaDiCal
Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics and driving local manufacturing, today announced the development of RaDiCal, a one-step molecular lateral flow test to enable rapid diagnosis of pneumonia, one of the most significant diseases affec
Assessing the impact of rarity on French HTA and pricing decisions
With changes to the pricing and access processes such as the new Accord Cadre and the soon-to-be implemented ATU reform likely to impact pricing and access of orphan products in France, Cécile Matthews
PhoreMost and ThinkCyte collaborate to advance AI based drug discovery
PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, and ThinkCyte K.K, a biotechnology company pioneering novel cell analysis and sorting instruments, today announced a strategic research partnership aimed at advancing modern
Sphere Fluidics appoints Richard Hammond as Chief Technical Officer
Key appointment forms part of ongoing plans to strengthen senior leadership team and support expansion of microfluidic product range for single cell analysis
Salus Wellness welcomes Emily Woollins to the team
Emily is an experienced Nutritional Therapist specializing in supporting clients with IBS (Irritable Bowel Syndrome) and other digestive disorders. She regularly works with clients suffering with pain, bloating, fatigue and suspected food intolerances.
Guardtech Group December Wrap-Up: a year of huge growth, joy and goodwill to all
As 2022 comes to a close, cleanroom construction specialists Guardtech joyously celebrate their busiest ever year.
How eligible patient numbers affect price of rare disease drugs in France
Having recently assessed the relationship between drug price and prevalence of non-oncology rare diseases, CRA’s Cécile Matthews, Bhavesh Patel, and Owen Male explore in greater depth the situation for these orphan
France’s ATU reform: Early access remains possible, but not all diseases are equal
When France’s ATU reform was implemented, some viewed it as restrictive.